Progressive Retinal Atrophy (PRA) is a hereditary eye condition in dogs that causes gradual vision loss, leading to blindness without pain but impacting a dog's daily quality of life. Although there is no cure or reversal for PRA, careful monitoring and genetic testing can help manage and reduce its spread among vulnerable breeds.
This disorder is inherited from parent dogs to their puppies and is not contagious. PRA targets the retina's photoreceptor cells—specifically the rods and cones responsible for sharpness and color vision.
Several forms of PRA exist, each associated with particular gene mutations, requiring specialized tests for each variant. Notably, Rod-Cone Dysplasia Type 1 (PRA-RCD1) is an early-onset variant commonly found in the Irish Setter breed in the United States. Signs typically appear well before the pup's first birthday.
PRA-RCD1 progressively damages both rods and cones in the retina, with degeneration beginning as early as 10 days of age—coinciding with when puppies start to open their eyes. Initial symptoms often include night blindness starting at about one month and advancing to total blindness by around 12 months.
The condition arises due to a recessive nonsense mutation in the PDE6B gene, leading to a defective enzyme critical for normal photoreceptor activity. This autosomal recessive inheritance requires dogs to inherit two copies of the faulty gene to develop symptoms.
This type of PRA mainly affects Irish Setters and their mixed-breed descendants. Early genetic screening and conscientious breeding are essential steps in curbing the occurrence of PRA-RCD1 in American lines.
Progressive Retinal Atrophy RCD1 follows an autosomal recessive pattern with various parental gene combinations affecting offspring as follows:
Knowing these inheritance probabilities is crucial for breeders striving to avoid producing affected pups.
To determine if your Irish Setter carries the PRA-RCD1 mutation, contact your local veterinary clinic to arrange genetic testing. Testing involves collecting a simple cheek swab or other DNA sample from the dog, which is then sent to accredited labs in the US for evaluation.
Veterinary genetic laboratories like the Orthopedic Foundation for Animals (OFA) or the University of Missouri can provide PRA-RCD1 testing services nationwide.
The results will categorize your dog as clear, a carrier, or affected—guiding thoughtful breeding decisions to prevent the disease from continuing.
Since no treatment exists for PRA-RCD1, genetic testing remains the most effective approach to lowering its incidence. Responsible breeders utilize test outcomes to avoid breeding two carriers or affected dogs together, thereby decreasing PRA-RCD1 prevalence in the American Irish Setter populations.
For pet owners, knowing their dog's PRA status helps prepare for potential vision challenges and adapt care as needed.
Brief Explanation: Progressive retinal atrophy (PRA) is an inherited group of eye disorders that cause gradual vision loss and eventual blindness in dogs.
The disease causes degeneration of the retina's light-sensitive cells. Different types exist and can affect breeds differently, ranging from early night blindness to complete vision loss over time.
Brief Explanation: Prevention involves DNA testing breeding dogs to identify carriers or affected animals, then ensuring breeding pairs are selected to avoid producing affected puppies.
Breeders predominantly rely on genetic screening for variants such as RCD1 to reduce affected litter risks. Choosing reputable breeders who perform these health tests is advised.
When seeking Irish Setter puppies, it’s important to select reputable Irish Setter breeders who conduct health tests like PRA screening. This promotes healthier pups with reduced chances of inherited disorders.
Ask breeders about their health testing protocols, request documentation, and consult breed clubs or American Kennel Club resources for recommendations.